394
Views
2
CrossRef citations to date
0
Altmetric
Research Articles

Temporal analysis of paracetamol-induced hepatotoxicity

ORCID Icon, , ORCID Icon, , , & show all
Pages 472-481 | Received 03 Sep 2021, Accepted 04 Mar 2022, Published online: 22 Mar 2022

References

  • Alvarenga, D., et al., 2018. Paradoxical role of matrix metalloproteinases in liver injury and regeneration after sterile acute hepatic failure. Cells, 7 (12), 247.
  • Bandeira, A.C.B., et al., 2017a. Lycopene inhibits reactive oxygen species production in SK-Hep-1 cells and attenuates acetaminophen-induced liver injury in C57BL/6 mice. Chemico-Biological Interactions, 263, 7–17.
  • Bandeira, A.C.B., et al., 2017b. Lycopene pretreatment improves hepatotoxicity induced by acetaminophen in C57BL/6 mice. Bioorganic & Medicinal Chemistry, 25 (3), 1057–1065.
  • Bhushan, B., et al., 2014. Pro-regenerative signaling after acetaminophen-induced acute liver injury in mice identified using a novel incremental dose model. The American Journal of Pathology, 184 (11), 3013–3025.
  • Brune, K., Renner, B., and Tiegs, G., 2015. Acetaminophen/paracetamol: a history of errors, failures and false decisions. European Journal of Pain, 19 (7), 953–913.
  • Curry, S.C., et al., 2015. Prolonged acetaminophen-protein adduct elimination during renal failure, lack of adduct removal by hemodiafiltration, and urinary adduct concentrations after acetaminophen overdose. Journal of Medical Toxicology, 11 (2), 169–178.
  • Donepudi, A.C., et al., 2019. Lack of multidrug resistance-associated protein 4 (Mrp4) alters the kinetics of acetaminophen toxicity. Toxicology Reports, 6 (June), 841–849.
  • DRAPER, H.H., et al., 1993. A comparative evaluation of thiobarbituric acid methods for the determination of malondialdehyde in biological materials. Free Radical Biology & Medicine, 15 (4), 353–363.
  • Duarte, S., et al., 2015. Matrix metalloproteinases in liver injury, repair and fibrosis. Matrix Biology, 44–46, 147–156.
  • Hart, S.G.E., et al., 1994. Acetaminophen nephrotoxicity in CD-1 Mice. I. Evidence of a role for in situ activation in selective covalent binding and toxicity. Toxicology and Applied Pharmacology, 126 (2), 267–275.,
  • Feng, S., and He, X., 2013. Mechanism-based inhibition of CYP450: an indicator of drug-induced hepatotoxicity. Current Drug Metabolism, 14 (9), 921–945.
  • Fu, C., et al., 2018. Platycodin D protects acetaminophen-induced hepatotoxicity by inhibiting hepatocyte MAPK pathway and apoptosis in C57BL/6J mice. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 107 (May), 867–877.
  • Geervliet, E., and Bansal, R., 2020. Matrix metalloproteinases as potential biomarkers. Cells, 9 (5), 1212.
  • Ghanem, C.I., et al., 2016. Acetaminophen; from liver to brain: new insights into drug pharmacological action and toxicity. Physiology & Behavior, 176 (1), 100–106.
  • Guo, H., et al., 2019. Shikonin attenuates acetaminophen-induced acute liver injury via inhibition of oxidative stress and inflammation. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 112 (October 2018), 108704.
  • Hussain, Z., et al., 2019. Protective effects of Cinnamomum zeylanicum L. (Darchini) in acetaminophen-induced oxidative stress, hepatotoxicity and nephrotoxicity in mouse model. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 109 (November 2018), 2285–2292.
  • Imaeda, A.B., et al., 2009. Acetaminophen-induced hepatotoxicity in mice is dependent on Tlr9 and the Nalp3 inflammasome. Journal of Clinical Investigation, 119 (2), 305–314.
  • Ito, Y., et al., 2005. Inhibition of matrix metalloproteinases minimizes hepatic microvascular injury in response to acetaminophen in mice. Toxicological Sciences, 83 (1), 190–196.
  • Jaeschke, H., et al., 2011. Current issues with acetaminophen hepatotoxicity-a clinically relevant model to test the efficacy of natural products. Life Sciences, 88 (17–18), 737–745.
  • Jaeschke, H., and Ramachandran, A., 2020. The role of oxidant stress in acetaminophen-induced liver injury. Current Opinion in Toxicology, 20–21, 9–14.
  • Jiang, Y., et al., 2016. Schisandrol B protects against acetaminophen-induced acute hepatotoxicity in mice via activation of the NRF2/ARE signaling pathway. Acta Pharmacologica Sinica, 37 (3), 382–389.
  • Jóźwiak-Bebenista, M., and Nowak, J.Z., 2014. Paracetamol: mechanism of action, applications and safety concern. Acta Poloniae Pharmaceutica, 71 (1), 11–23.
  • Kato, H., et al., 2014. MMP-9 deficiency shelters endothelial pecam-1 expression and enhances regeneration of steatotic livers after ischemia and reperfusion injury. Journal of Hepatology, 60 (5), 1032–1039.
  • Kim, E.H., and Park, P.H., 2018. Globular adiponectin protects rat hepatocytes against acetaminophen-induced cell death via modulation of the inflammasome activation and ER stress: critical role of autophagy induction. Biochemical Pharmacology, 154, 278–292.
  • Klein, T.E., et al., 2015. PharmGKB summary: succinylcholine pathway, pharmacokinetics/pharmacodynamics. Pharmacogenetics and Genomics, 25 (12), 622–630.
  • Levine, R.L., et al., 1991. Carbonyl assays for determination of oxidatively modified proteins. Methods in Enzymology, 186, 346–357.
  • Li, Y., et al., 2019. Chlorpromazine protects against acetaminophen-induced liver injury in mice by modulating autophagy and c-Jun N-terminal kinase activation. Liver Research, 3 (1), 65–74.
  • Lowry, O.H., et al., 1951. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry, 193 (1), 265 e 275–275.
  • Lúcio, K.D.P., et al., 2018. Anti-inflammatory and antioxidant properties of black mulberry (Morus nigra L.) in a model of LPS-induced sepsis. Oxidative Medicine and Cellular Longevity, 2018, 1–13.
  • Marques, P.E., et al., 2012. Chemokines and mitochondrial products activate neutrophils to amplify organ injury during mouse acute liver failure. Hepatology, 56 (5), 1971–1982.
  • Mazraati, P., and Minaiyan, M., 2018. Hepatoprotective effect of metadoxine on acetaminophen-induced liver toxicity in mice. Advanced Biomedical Research, 7 (1), 67.
  • Minsart, C., et al., 2020. N-acetylcysteine and glycyrrhizin combination: benefit outcome in a murine model of acetaminophen-induced liver failure. World Journal of Hepatology, 12 (9), 596–618.
  • Perwitasari, D.A., Atthobari, J., and Wilffert, B., 2015. Pharmacogenetics of isoniazid-induced hepatotoxicity. Drug Metabolism Reviews, 47 (2), 222–228.
  • Rabelo, A.C.S., et al., 2018. Baccharis trimera protects against ethanol induced hepatotoxicity in vitro and in vivo. Journal of Ethnopharmacology, 215 (December 2017), 1–13.
  • Ramachandran, A., and Jaeschke, H., 2019. Acetaminophen hepatotoxicity. Seminars in Liver Disease, 39 (2), 221–234.
  • Rumack, B.H., and Bateman, D.N., 2012. Acetaminophen and acetylcysteine dose and duration: past, present and future. Clinical Toxicology, 50 (2), 91–98.
  • Salem, G.A., et al., 2018. Phoenix dactylifera protects against oxidative stress and hepatic injury induced by paracetamol intoxication in rats. Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, 104 (May), 366–374.
  • Sedlak, J., and Lindsay, R.H., 1968. Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman’s reagent. Analytical Biochemistry, 25 (1), 192–205.
  • Shan, S., et al., 2019. Mitophagy protects against acetaminophen-induced acute liver injury in mice through inhibiting NLRP3 inflammasome activation. Biochemical Pharmacology, 169, 113643.
  • Singh, A., Bhat, T.K., and Sharma, O.P., 2011. Clinical Biochemistry of Hepatotoxicity. Journal of Clinical Toxicology, 4 (1), 1–19.
  • Sung, M.M., et al., 2007. Matrix metalloproteinase-2 degrades the cytoskeletal protein alpha-actinin in peroxynitrite mediated myocardial injury. Journal of Molecular and Cellular Cardiology, 43 (4), 429–436.
  • Thusius, N.J., Romanowicz, M., and Bostwick, J.M., 2019. Intentional or inadvertent acetaminophen overdose—how lethal it really is? Psychosomatics, 60 (6), 574–581.
  • Woolbright, B.L., and Jaeschke, H., 2017. Role of the inflammasome in acetaminophen-induced liver injury and acute liver failure. Journal of Hepatology, 66 (4), 836–848.
  • Ye, D., et al., 2014. Fibroblast growth factor 21 protects against acetaminophen-induced hepatotoxicity by potentiating peroxisome proliferator-activated receptor coactivator protein-1 a -mediated antioxidant capacity in mice. Hepatology, 60 (3), 977–989.
  • Zhang, C., et al., 2018. Macrophage-derived IL-1 α promotes sterile inflammation in a mouse model of acetaminophen hepatotoxicity. Cellular & Molecular Immunology, 15 (11), 973–982.
  • Zhou, Z., et al., 2021. Orostachys japonicus ameliorates acetaminophen-induced acute liver injury in mice. Journal of Ethnopharmacology, 265 (March 2020), 113392.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.